Page last updated: 2024-08-22

tiletamine hydrochloride and Alopecia

tiletamine hydrochloride has been researched along with Alopecia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hosaka, Y; Kato, K; Mochizuki, H; Muramatsu, H; Nagata, S; Nakamura, N; Nakayama, K; Ohmori, Y; Saitoh, F; Takiguchi, K; Tsuda, T	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Alopecia

Article	Year
Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia. European journal of pharmacology, 2001, Dec-14, Volume: 433, Issue:1 Topics: Alopecia; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; COS Cells; Cyclohexanones; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; Female; Hepatitis; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; U937 Cells	2001

Article

Year

Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia.

European journal of pharmacology, 2001, Dec-14, Volume: 433, Issue:1

Topics: Alopecia; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; COS Cells; Cyclohexanones; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; Female; Hepatitis; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; U937 Cells

2001